PROVIDENCE – Rhode Island Hospital Alzheimer’s Disease and Memory Disorders Center researchers are recruiting volunteers for TANGO, a national clinical trial evaluating whether a new drug using antibodies to target tau protein in the brains of people with the disease is an effective treatment. The trial is sponsored by Biogen, based in Massachusetts. The drug,…
Want More Free?
To access 2 more articles, please log in or register for free.
Registered users get access to a limited number of free articles every month.